Caxton Corp

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Caxton Corp
CIK #0001014708, 0001388551
CIK Period
0001014708 0001388551
Sector Form 13F Holdings Value ($M)
SPDR Gold Trust 3.3
Kyverna Therapeutics Inc 0.2
Lexeo Therapeutics Inc 0.1
Arsanis Inc 0.1
Inhibikase Therapeutics Inc 0.0
ALX Oncology Holdings Inc 0.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2026
3 [0001014708]
SC 13D [0001014708]
SC 13G [0001014708]
13F-HR [0001388551]
3 [0001388551]
4 [0001388551]
SC 13D [0001388551]
SC 13G [0001388551]
Form 13D/13G Filer Form 13D/13G Subject Filed
Caxton Corp Xeris Biopharma Holdings Inc [2022-01-05]
Caxton Corp Savara Inc [2021-03-19]
Caxton Corp Addex Therapeutics Ltd [2021-02-16]
Caxton Corp Rezolute Inc [2020-10-14]
Caxton Corp CTI Biopharma Corp [2020-10-02]
Caxton Corp Cardiff Oncology Inc [2020-06-22]
Caxton Corp Sierra Oncology Inc [2020-02-03]
Caxton Corp Satsuma Pharmaceuticals Inc [2019-10-21]
Caxton Corp Sunesis Pharmaceuticals Inc [2019-07-19]
Caxton Corp Alcentra Capital Corp [2019-02-04]
View All
Form 3/4/5 Subject 2011 - 2026
Kovner Bruce
CDK Associates LLC
Strongbridge Biopharma plc
Caxton Corp
Molecular Templates, Inc.
Morenstein Scott D
KALA BIO, Inc.
Celator Pharmaceuticals Inc
Canterbury Holdings Ltd
Caxton International Ltd
View All
Terms | Privacy | Guide
tony@aum13f.com